Cargando…

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment

Gambogic acid (GA) is expected to be a potential new antitumor drug, but its poor aqueous solubility and inevitable side effects limit its clinical application. Despite these inhe rent defects, various nanocarriers can be used to promote the solubility and tumor targeting of GA, improving antitumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhen, Qian, Hanqing, Yang, Mi, Li, Rutian, Hu, Jing, Li, Li, Yu, Lixia, Liu, Baorui, Qian, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339001/ https://www.ncbi.nlm.nih.gov/pubmed/28280328 http://dx.doi.org/10.2147/IJN.S127256

Ejemplares similares

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2018)

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog
por: Gao, Guangyi, et al.
Publicado: (2018)

Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
por: Zhang, Dinghu, et al.
Publicado: (2020)

Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
por: Zou, Zhengyun, et al.
Publicado: (2012)

Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth
por: Wu, Puyuan, et al.
Publicado: (2018)

Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells
por: Huang, Fengli, et al.
Publicado: (2023)

Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer
por: Zhang, Lianru, et al.
Publicado: (2017)

Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
por: Yao, Jing, et al.
Publicado: (2014)

Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles
por: Li, Rutian, et al.
Publicado: (2011)

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
por: Li, Rutian, et al.
Publicado: (2013)

Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment
por: Liu, Yuling, et al.
Publicado: (2023)

Using Omniscan-Loaded Nanoparticles as a Tumor-Targeted MRI Contrast Agent in Oral Squamous Cell Carcinoma by Gelatinase-Stimuli Strategy
por: Gao, Antian, et al.
Publicado: (2019)

Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels
por: Wang, Qiang, et al.
Publicado: (2018)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

Nanoemulsion Co-Loaded with XIAP siRNA and Gambogic Acid for Inhalation Therapy of Lung Cancer
por: Xu, Minhao, et al.
Publicado: (2022)

Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid
por: Li, Mingzhu, et al.
Publicado: (2022)

Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)

Nuclear Targeted Peptide Combined With Gambogic Acid for Synergistic Treatment of Breast Cancer
por: Dang, Wenli, et al.
Publicado: (2022)

A Gamboge Case
por: Biegler, J. A.
Publicado: (1887)

Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
por: Wang, Qin, et al.
Publicado: (2020)

Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells
por: WEN, CHUANGYU, et al.
Publicado: (2015)

Aminated β-cyclodextrin-grafted Fe(3)O(4)-loaded gambogic acid magnetic nanoparticles: preparation, characterization, and biological evaluation
por: Fang, Wei, et al.
Publicado: (2019)

MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT
por: Qian, Lingyu, et al.
Publicado: (2020)

Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
por: Huang, Rui, et al.
Publicado: (2018)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge
por: Cheng, Li-Zhi, et al.
Publicado: (2022)

Biomimetic nanoparticles for tumor immunotherapy
por: Yu, Hanqing, et al.
Publicado: (2022)

Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response
por: Xu, Hanjie, et al.
Publicado: (2022)

Gambogic Acid Lysinate Induces Apoptosis in Breast Cancer MCF-7 Cells by Increasing Reactive Oxygen Species
por: Zhen, Yong-Zhan, et al.
Publicado: (2015)

Effect of Gambogic Acid–Loaded Porous-Lipid/PLGA Microbubbles in Combination With Ultrasound-Triggered Microbubble Destruction on Human Glioma
por: Wang, Feng, et al.
Publicado: (2021)

Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells
por: Chen, Baoan, et al.
Publicado: (2009)

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line
por: Yang, Yang, et al.
Publicado: (2015)

Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro
por: Chen, Jinhao, et al.
Publicado: (2015)

Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS
por: Liu, Jiang, et al.
Publicado: (2016)

Effect of Gambogic Acid on miR-199a-3p Expression and Cell Biological Behavior in Colorectal Cancer Cells
por: Wang, Xiaodong, et al.
Publicado: (2021)

FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis
por: Chen, Datian, et al.
Publicado: (2018)

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
por: Zhang, Jingyu, et al.
Publicado: (2016)

Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke
por: Chen, Junfa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hi1338n0i9gq41rocg9hh66hq